VERTEX PHARMACEUTICALS/ US92532F1003 /
| 2024-04-29 8:01:02 PM | Chg. -21.85 | Volume | Bid3:01:07 AM | Ask3:01:07 AM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 371.75EUR | -5.55% | 3 Turnover: 1,115.25 |
-Bid Size: - | -Ask Size: - | 95.45 bill.EUR | - | - |
GlobeNewswire
04-27
SHAREHOLDER INVESTIGATION NOTICE: Halper Sadeh LLC Investigates MODN, AIRC, INRD, ALPN
GlobeNewswire
04-22
TAKE ACTION: The M&A Class Action Firm Launches Legal Inquiry for the Merger - ALPN, LABP, SWAV, FUS...
GlobeNewswire
04-22
CRISPR Therapeutics to Present Oral Presentation at the American Society of Gene & Cell Therapy (ASG...
GlobeNewswire
04-09
American Kidney Fund and Alonzo Mourning Call for More Awareness and Understanding of APOL1-Mediated...
GlobeNewswire
04-03
CRISPR Therapeutics to Present at the Annual Needham Virtual Healthcare Conference
GlobeNewswire
04-01
CervoMed Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Updates
GlobeNewswire
04-01
CRISPR Therapeutics to Present at the American Society of Gene & Cell Therapy (ASGCT) 2024 Annual Me...
GlobeNewswire
03-15
American Kidney Fund Announces 2024 Class of Corporate Members Providing Support in the Fight Agains...
GlobeNewswire
03-13
Entrada Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results
GlobeNewswire
03-12
MaxCyte Reports Fourth Quarter and Full Year 2023 Financial Results and Reiterates 2024 Guidance
GlobeNewswire
03-12
UNCF 80th Anniversary Gala in Boston Raises More than $750K to Support HBCUs and Students
GlobeNewswire
02-29
Kidney Month: 31 Day of Action to Equip and Empower People to Fight Kidney Disease
GlobeNewswire
02-28
Editas Medicine Announces Fourth Quarter and Full Year 2023 Results and Business Updates
GlobeNewswire
02-27
Verve Therapeutics Provides Pipeline Progress and Reports Fourth Quarter and Full Year 2023 Financia...
GlobeNewswire
02-26
Disc Medicine Expands Leadership Team with Appointment of Industry Veteran Pamela Stephenson, MPH as...
